Cocrystal design of vanillin with amide drugs: Crystal structure determination, solubility enhancement, DFT calculation

共晶 溶解度 化学 差示扫描量热法 溶解 异烟酰胺 粉末衍射 烟酰胺 傅里叶变换红外光谱 升华(心理学) 材料科学 物理化学 结晶学 化学工程 有机化学 分子 氢键 热力学 心理治疗师 工程类 物理 心理学
作者
Jinbo Ouyang,Xiaohong Xing,Limin Zhou,Chuntao Zhang,Jerry Y. Y. Heng
出处
期刊:Chemical Engineering Research & Design [Elsevier BV]
卷期号:183: 170-180 被引量:16
标识
DOI:10.1016/j.cherd.2022.05.009
摘要

Vanillin (VAN) is widely used in medicine, food and optoelectronics, but its low solubility leads to the decrease of bioavailability and increase of application costs. Three APIs-nicotinamide (NIC), isonicotinamide (INM) and isoniazid (INH) were chosen to form cocrystals with VAN, aiming at improving the solubility of VAN and APIs simultaneously. Two cocrystals (VAN-NIC, VAN-INM) were obtained through cocrystallization while VAN reacted with INH to form one novel compound (VAN-INH). The crystal structures were characterized by single-crystal X-ray diffraction (SCXRD), Powder X-ray diffraction (PXRD), Fourier-Transform Infrared Spectroscopy (FT-IR) and Differential Scanning Calorimetry (DSC). The melting temperatures of VAN-NIC and VAN-INM cocrystals are between this of VAN and APIs. Compared with pure VAN and APIs, the solubility and dissolution rate of VAN-NIC and VAN-INM are significantly increased. The melting temperature of VAN-INH is greater than that of VAN and INH, and the solubility and dissolution rate is not increased significantly. The intermolecular energy between VAN and APIs as well as lattice energies of cocrystals/novel compound were computed to elucidate the formation mechanism and stability. The present investigation opens a new pathway for the development of natural product-drug cocrystals to improve solubility and dissolution rate of natural product.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
砰砰彭发布了新的文献求助20
2秒前
爆米花应助王多肉采纳,获得10
3秒前
山南驳回了打打应助
5秒前
Chaos完成签到,获得积分10
5秒前
5秒前
遇上就这样吧应助kento采纳,获得50
6秒前
7秒前
7秒前
8秒前
9秒前
梨花月应助司空元正采纳,获得10
9秒前
10秒前
学fei了吗完成签到,获得积分10
10秒前
11完成签到,获得积分10
12秒前
12秒前
浮游应助咿呀呀采纳,获得10
12秒前
孙勇发发布了新的文献求助10
13秒前
量子星尘发布了新的文献求助10
14秒前
天天快乐应助神秘人采纳,获得10
17秒前
18秒前
友好德天完成签到 ,获得积分10
20秒前
浮游应助风中的身影采纳,获得10
21秒前
21秒前
真水无香完成签到,获得积分10
23秒前
量子星尘发布了新的文献求助10
25秒前
怕孤独的忆南完成签到,获得积分10
25秒前
Melody发布了新的文献求助10
26秒前
26秒前
27秒前
浮游应助lllll采纳,获得10
27秒前
28秒前
情怀应助小冯采纳,获得10
28秒前
29秒前
29秒前
科研通AI6应助Seven采纳,获得20
29秒前
29秒前
xc完成签到,获得积分10
30秒前
30秒前
王瑶完成签到,获得积分20
31秒前
高分求助中
Comprehensive Toxicology Fourth Edition 24000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
World Nuclear Fuel Report: Global Scenarios for Demand and Supply Availability 2025-2040 800
Handbook of Social and Emotional Learning 800
Risankizumab Versus Ustekinumab For Patients with Moderate to Severe Crohn's Disease: Results from the Phase 3B SEQUENCE Study 600
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5135008
求助须知:如何正确求助?哪些是违规求助? 4335582
关于积分的说明 13507290
捐赠科研通 4173211
什么是DOI,文献DOI怎么找? 2288286
邀请新用户注册赠送积分活动 1289005
关于科研通互助平台的介绍 1230049